ラクオリア創薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4579/E25269 | RaQualia Pharma Inc. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2014/06/13 | 日証協 | 824,980株 | +1.12% | 7,000株 | -85.69% | 537,299株 | +0.73% | 9,500株 | -42.77% |
2014/06/06 | 日証協 | 815,880株 | -0.15% | 48,900株 | +81.78% | 533,399株 | +0.83% | 16,600株 | 0% |
2014/05/30 | 日証協 | 817,080株 | -0.07% | 26,900株 | -75.25% | 529,000株 | -0.53% | 16,600株 | -70.09% |
2014/05/23 | 日証協 | 817,680株 | +1.99% | 108,680株 | +201.89% | 531,800株 | +0.06% | 55,500株 | +125.43% |
2014/05/16 | 日証協 | 801,760株 | -1.62% | 36,000株 | +471.43% | 531,480株 | +0.32% | 24,620株 | -7.79% |
2014/05/09 | 日証協 | 814,960株 | -1.57% | 6,300株 | -96.12% | 529,780株 | -0.82% | 26,700株 | +66.88% |
2014/05/02 | 日証協 | 827,960株 | +10.93% | 162,280株 | +39.7% | 534,180株 | +8.68% | 16,000株 | -78.55% |
2014/04/25 | 日証協 | 746,400株 | 0% | 116,160株 | +1085.31% | 491,500株 | +1.59% | 74,580株 | +378.08% |
2014/04/18 | 日証協 | 746,400株 | -0.15% | 9,800株 | -91.52% | 483,800株 | -0.78% | 15,600株 | -76.79% |
2014/04/11 | 日証協 | 747,500株 | +7.77% | 115,500株 | +2121.15% | 487,600株 | +6.37% | 67,200株 | +386.96% |
2014/04/04 | 日証協 | 693,600株 | -0.59% | 5,200株 | -5.45% | 458,403株 | +1.46% | 13,800株 | +160.38% |
2014/03/28 | 日証協 | 697,700株 | +0.26% | 5,500株 | -37.5% | 451,808株 | +0.38% | 5,300株 | -42.39% |
2014/03/20 | 日証協 | 695,900株 | +0.88% | 8,800株 | +700% | 450,103株 | -1.06% | 9,200株 | -2.13% |
2014/03/14 | 日証協 | 689,800株 | -0.38% | 1,100株 | -42.11% | 454,903株 | +1.14% | 9,400株 | +123.28% |
2014/03/07 | 日証協 | 692,400株 | -0.2% | 1,900株 | -96.56% | 449,793株 | -2.3% | 4,210株 | -89.68% |
2014/02/28 | 日証協 | 693,800株 | +0.27% | 55,300株 | +360.83% | 460,393株 | +1.28% | 40,800株 | +96.15% |
2014/02/21 | 日証協 | 691,900株 | +0.29% | 12,000株 | +172.73% | 454,593株 | -1.81% | 20,800株 | +395.24% |
2014/02/14 | 日証協 | 689,900株 | -0.27% | 4,400株 | -90.7% | 462,993株 | +3.04% | 4,200株 | -91.07% |
2014/02/07 | 日証協 | 691,800株 | +3.15% | 47,300株 | +45.99% | 449,313株 | +3.94% | 47,020株 | +331.26% |
※株式分割は考慮していませんのでご注意ください。
Page Top